ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -30.8% | 5,847 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -38.1% | 5,847 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -47.5% | 5,847 | -15.2% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 6,896 | -12.5% | 0.00% | – |
| Q1 2021 | $41,000 | +127.8% | 7,877 | +4.4% | 0.00% | – |
| Q4 2020 | $18,000 | +80.0% | 7,545 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -28.6% | 7,545 | +6.4% | 0.00% | – |
| Q2 2020 | $14,000 | +100.0% | 7,094 | +143.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 2,919 | -32.7% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 4,339 | +21.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 3,576 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | +800.0% | 3,576 | +831.2% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 384 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -87.5% | 384 | -81.8% | 0.00% | – |
| Q3 2017 | $16,000 | +45.5% | 2,115 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 2,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |